Plan your participation in the ESMO Targeted Anticancer Therapies Congress 2024, taking place in Paris, France, on 26-28 February 2024.
ESMO TAT offers participants a glimpse into the future of anticancer therapies, focusing on promising new targets and agents with a particular emphasis on early drug development.
New for 2024, Speakers from both academia and industry will participate in an expanded programme, including four new joint ESMO-Industry special sessions addressing drug development, methodological, regulatory, strategic financing and investment issues, offering attendees a fresh, wide-ranging perspective on the development of innovative cancer therapeutics and their optimal implementation.
Empowering the expression of views of stakeholders beyond academia, such as from industry, investors and regulators, will enrich the educational and scientific content of ESMO TAT 2024 in a fascinating arena of therapeutic innovation.
How can I participate at ESMO TAT 2024?
At ESMO we are committed to providing our industry partners with a variety of solutions to facilitate their presence at our congress.
For sponsorship information and a prospectus please contact:
Jon Roberts
Head of Strategic Partnerships
jon.roberts@esmo.org
Anna MacDougall
Strategic Partnerships Manager
anna.macdougall@esmo.org
Francesca Iadicicco
Strategic Projects Manager
francesca.iadicicco@esmo.org
We look forward to hearing from you!